Abeona Therapeutics Inc. (ABEO)
Nasdaq: ABEO · Pharmaceutical Preparations · Cleveland, OH · filing with the SEC since 1995
Who owns Abeona Therapeutics Inc.
As filed with the SECHolders of 5% or more
7
Nantahala Capital Management, LLC holds 9.99% of Common Stock, $0.01 par value, as its SCHEDULE 13G/A filed May 15, 2026 says.
Directors and officers
13
report now, of 30 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 7 named at left.
Holders of 5% or moreshare of the class, as filed
Nantahala Capital Management, LLC
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, $0.01 par value · 9.99% in Oct 6, 2025
James Russell Revocable Trust
SCHEDULE 13D · filed Oct 23, 2026 · Common Stock, $0.01 par value · 5.3% in Sep 30, 2025
Nantahala Capital Partners Limited Partnership
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, $0.01 par value · 5.09% in Oct 6, 2025
Blackrock, Inc.
SCHEDULE 13G · filed Jul 17, 2025 · Common Stock
Orin Hirschman
SCHEDULE 13G · filed Apr 28, 2026 · Common Stock, $0.01 par value
Funicular Funds, LP
SCHEDULE 13G · filed Apr 6, 2026 · Common Stock, par value $0.01
Daniel Kaufman
SCHEDULE 13G · filed Mar 27, 2026 · Common Stock, $0.01 par value
Millennium Management LLC
SCHEDULE 13G/A · filed May 1, 2025 · Common Stock, par value $0.01 per share · reported falling below 5%
Montanova Capital, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, $0.01 par value · reported falling below 5%, from 5.2% in Aug 13, 2025
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%, from 5.07% in Oct 30, 2025
Adage Capital Management, L.P.
SCHEDULE 13G/A · filed Feb 12, 2026 · Common Stock, par value $0.01 per share · reported falling below 5%, from 9.99% in Nov 13, 2025
What ABEO reports owning in othersstakes of 5% or more, and other ties
2 subsidiaries in 1 country, from the list filed with the 10-K filed Mar 17, 2026.
Insider tradesForm 4
39sales
0purchases
6sales on a scheduled plan
9people selling
$3.6Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window9 of 35 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Seshadri Vishwas | Chief Executive Officer | 9 | $1.6M | 3 | 0 | $0 |
| Vazzano Joseph Walter | Chief Financial Officer | 8 | $600,000 | 3 | 0 | $0 |
| O'Malley Brendan M. | SVP, Chief Legal Officer | 5 | $300,000 | 0 | 0 | $0 |
| Vasanthavada Madhav | Chief Commercial Officer | 6 | $300,000 | 0 | 0 | $0 |
| Alvino Mark | director | 5 | $300,000 | 0 | 0 | $0 |
| Silverstein Christine Berni | Chief Financial Officer | 2 | $200,000 | 0 | 0 | $0 |
| Alland Leila | director | 2 | $200,000 | 0 | 0 | $0 |
| Crombez Eric | director | 2 | $200,000 | 1 | 0 | $0 |
| Wuchterl Donald A. | director | 1 | $100,000 | 0 | 0 | $0 |